John R Fischer

PE backs patient engagement tech: 5 deals

Clearlake Capital, Marlin Equity Partners and New Mountain Capital are among the PE firms investing in patient engagement software.

Carlyle, Longshore, Serent go for RCM platforms; Federal rules drive SEVA to healthcare price transparency sector

Vendors providing revenue cycle management are attracting attention from PE dealmakers, like Carlyle, Longshore Capital Partners and Serent Capital; SEVA announced an investment in the healthcare price transparency sector this week.

PE backs specialty-focused healthcare RCM services: 8 deals

Carlyle, Francisco Partners, New Mountain and Serent are among the PE firms investing in revenue cycle management platforms.

Exclusive: TJC to launch sale of Dental365 in 2027, sources say

Dental365 could fetch a valuation based on $75m-$100m of EBITDA generated over the last year, said two sources.

Butterfly, Graham, Wise Equity target nutraceuticals; Demand for antimicrobial testing drives Astorg’s $1bn carve-out of Thermo Fishers’ microbiology biz

Butterfly Equity, Graham Partners and Wise Equity are among the firms transacting with nutraceuticals assets.

PE targets opportunities in nutraceuticals: 7 deals

Butterfly Equity, Gryphon Investors, Frontenac and Wise Equity are targeting platforms in the nutraceuticals sector.

HarbourVest eyes transformative trends in AI and healthcare innovation with HCF VII

HarbourVest's Joel Hwang and Jackie Peradotto outline plans for deploying the firm's seventh flagship co-investment fund, which recently held a final close of $4.75bn.

Medical education gap presents an opportunity for private equity

The pressing need for more healthcare professionals globally is proving a tailwind for PE investors in medical education.

Wise Equity inks agreement to acquire E-Pharma Trento

E-Pharma Trento will possibly explore bolt-on acquisitions to add new technologies or enhance its manufacturing capacity.

Eir Partners invests in ClaimsBridge, supports add-on of DialysisPPO

Eir Partners plans to scale ClaimsBridge's platform organically and inorganically, including through M&A.